NCT03598192View on ClinicalTrials.gov

The Effect and Safety of the Four Points Transversus Abdominis Plane Block

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

July 30, 2020

Conditions
Liver DiseasesAdult Disease
Interventions
PROCEDURE

TAP

The TAP group will be performed at four points at abdominis plane with ropivacaine 0.375%

PROCEDURE

PVB

The PVB group will be performed at paravertebral space T7 with ropivacaine 0.5%

DRUG

Ropivacaine

Ropivacaine has been treated the both group

DRUG

Sufentanil

Sufentanil has been included in Arm/Group Descriptions

Trial Locations (1)

70000

Binh Huynh, Ho Chi Minh City

All Listed Sponsors
lead

Gia Dinh People Hospital

OTHER

NCT03598192 - The Effect and Safety of the Four Points Transversus Abdominis Plane Block | Biotech Hunter | Biotech Hunter